Stephen J Thomas Selected Research

Dengue Vaccines

1/2021	Correlation between reported dengue illness history and seropositivity in rural Thailand.
1/2021	Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial.
4/2020	When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?
1/2020	The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States.
1/2020	Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1.
1/2019	Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions.
12/2018	Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection.
10/2018	The dynamic role of dengue cross-reactive immunity: changing the approach to defining vaccine safety and efficacy.
1/2018	Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.
1/2016	Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Thomas Research Topics

Disease

39	Dengue (Dengue Fever) 01/2022 - 01/2009
34	Infections 01/2022 - 06/2006
7	COVID-19 08/2022 - 12/2020
7	Pain (Aches) 04/2021 - 03/2014
6	Zika Virus Infection 01/2022 - 08/2017
6	Viremia 01/2017 - 06/2006
4	Severe Dengue 09/2020 - 09/2015
4	Japanese Encephalitis 01/2020 - 05/2010
4	Yellow Fever 01/2020 - 04/2010
3	Headache (Headaches) 01/2021 - 01/2020
3	Fatigue 01/2021 - 01/2020
2	Neoplasms (Cancer) 05/2022 - 01/2022
2	Rabies (Hydrophobia) 01/2020 - 01/2020
2	Human Influenza (Influenza) 12/2016 - 10/2014
2	Coinfection 09/2015 - 01/2009
2	Fever (Fevers) 01/2013 - 03/2008
1	Hypersensitivity (Allergy) 08/2022
1	Hypertrophy 02/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Healthcare-Associated Pneumonia 12/2021
1	Bacterial Pneumonia 12/2021
1	Urinary Tract Infections (Urinary Tract Infection) 12/2021
1	Gram-Negative Bacterial Infections 12/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Tendinopathy (Tendonitis) 10/2020
1	Poisoning 01/2020
1	Asymptomatic Infections 12/2018
1	Rotator Cuff Injuries 10/2017
1	Vesicular Stomatitis 01/2017
1	Shock 08/2016
1	Microcephaly 08/2016
1	Guillain-Barre Syndrome 08/2016

Drug/Important Bio-Agent (IBA)

48	VaccinesIBA 08/2022 - 06/2006
16	Dengue VaccinesIBA 01/2021 - 01/2009
12	Neutralizing AntibodiesIBA 01/2022 - 03/2008
5	AntibodiesIBA 05/2022 - 10/2014
5	Inactivated VaccinesIBA 01/2020 - 04/2015
4	BNT162 VaccineIBA 01/2022 - 12/2020
4	Immunoglobulin M (IgM)IBA 01/2021 - 01/2013
4	Pharmaceutical PreparationsIBA 10/2018 - 07/2013
3	Capsules (Microcapsules)IBA 02/2022 - 11/2014
3	EpitopesIBA 04/2020 - 01/2014
3	Antiviral Agents (Antivirals)IBA 10/2013 - 06/2011
2	AntigensIBA 01/2022 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2021 - 04/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 04/2020
2	Immunoglobulin A (IgA)IBA 01/2021 - 04/2020
2	Japanese Encephalitis VaccinesIBA 01/2020 - 09/2013
2	CytokinesIBA 12/2018 - 04/2002
2	Combined VaccinesIBA 01/2018 - 01/2009
2	ChimeriVaxIBA 05/2010 - 04/2010
1	mRNA VaccinesIBA 05/2022
1	COVID-19 VaccinesIBA 01/2022
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 12/2021
1	Meropenem (Merrem)FDA LinkGeneric 12/2021
1	CefiderocolIBA 12/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2021
1	SiderophoresIBA 12/2021
1	IgG Receptors (Fc gamma RI)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 01/2020
1	Heroin (Diamorphine)IBA 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	proguanil drug combination atovaquone (malarone)FDA Link 01/2020
1	Opiate AlkaloidsIBA 01/2020
1	Interleukin-12 (IL 12)IBA 12/2018
1	Interleukin-15 (Interleukin 15)IBA 12/2018
1	Chemokine CCL5IBA 12/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2018
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	Dacarbazine (DIC)FDA LinkGeneric 10/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	LipidsIBA 01/2018
1	Interferon Type IIBA 01/2018
1	delafloxacinIBA 01/2018
1	vaxfectinIBA 01/2018
1	FluoroquinolonesIBA 01/2018
1	DNA VaccinesIBA 01/2018
1	aluminum sulfate (alum)IBA 06/2017
1	AS03 adjuvantIBA 06/2017
1	Aluminum Hydroxide (Algeldrate)FDA Link 06/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2016
1	Explosive Agents (Explosives)IBA 08/2016
1	ProteomeIBA 09/2015
1	HLA-B44 AntigenIBA 09/2015
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 05/2015

Therapy/Procedure

4	Therapeutics 05/2022 - 10/2020
1	Mechanical Ventilators (Ventilator) 12/2021
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2020
1	Extracorporeal Shockwave Therapy 10/2020
1	Low-Level Light Therapy (LLLT) 10/2020
1	Injections 10/2020
1	Tenotomy 10/2017
1	Aftercare (After-Treatment) 10/2017
1	Resuscitation 08/2016